Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making

摘要

BackgroundMedication decision-making poses a challenge for a significant proportion of patients. This is an even more challenging for patients who have complex, rare, immune conditions that affect them at a young age and are associated with the use of life-long treatment, perceived by some as having significant risk of side effects and toxicity.